Keywords: glucagon-like peptide-1 receptor agonist, health technology assessment, type 2 diabetes mellitus, drug evaluation Introduction Hospital-based health technology assessment (HB-HTA) refers to the comprehensive and systematic evaluation of relevant health technologies based on the actual needs of hospitals, using the principles and methods of evidence-based medicine and health technology assessment to make rapid decisions about the selection, acquisition, and use of new technologies to improve health equity and is a commonly used policy analysis tool internationally
For diabetic patients, weigh glycemic control needs against surgical risks and consult endocrinology if preoperative insulin changes were significant
doi:10.7326/M20-2470 18
Endocrinology 151 , 143152 (2010)
After treatment with BN for 3 months, BMI, fasting blood glucose, glycosylated hemoglobin, visceral and subcutaneous fat, silk protein E1, leptin, C-reactive protein (CRP), and tumor necrosis factor decreased significantly
According to the 2016 review, avocados may increase GLP-1 levels through their high content of fiber and monounsaturated fats
